A systematic review and meta-analysis of community and primary-care-based hepatitis C testing and treatment services that employ direct acting antiviral drug treatments

BACKGROUND: Direct Acting Antiviral (DAAs) drugs have a much lower burden of treatment and monitoring requirements than regimens containing interferon and ribavirin, and a much higher efficacy in treating hepatitis C (HCV). These characteristics mean that initiating treatment and obtaining a virolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Radley, Andrew, Robinson, Emma, Aspinall, Esther J., Angus, Kathryn, Tan, Lex, Dillon, John F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819346/
https://www.ncbi.nlm.nih.gov/pubmed/31660966
http://dx.doi.org/10.1186/s12913-019-4635-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819346/
https://www.ncbi.nlm.nih.gov/pubmed/31660966
http://dx.doi.org/10.1186/s12913-019-4635-7

Ejemplares similares